Alexander C Perino1, Jun Fan2, Susan K Schmitt2, Mariam Askari2, Daniel W Kaiser1, Abhishek Deshmukh3, Paul A Heidenreich1, Christopher Swan1, Sanjiv M Narayan1, Paul J Wang1, Mintu P Turakhia4. 1. Department of Medicine, Stanford University School of Medicine, Stanford, California; Veterans Affairs Palo Alto Health Care System, Palo Alto, California. 2. Veterans Affairs Palo Alto Health Care System, Palo Alto, California. 3. Mayo Clinic, Rochester, Minnesota. 4. Department of Medicine, Stanford University School of Medicine, Stanford, California; Veterans Affairs Palo Alto Health Care System, Palo Alto, California; Center for Digital Health, Stanford University School of Medicine, Stanford, California. Electronic address: mintu@stanford.edu.
Abstract
BACKGROUND: Atrial fibrillation (AF) occurs in many clinical contexts and is diagnosed and treated by clinicians across many specialties. This approach has resulted in treatment variations. OBJECTIVES: The goal of this study was to evaluate the association between treating specialty and AF outcomes among patients newly diagnosed with AF. METHODS: Using data from the TREAT-AF (Retrospective Evaluation and Assessment of Therapies in AF) study from the Veterans Health Administration, patients with newly diagnosed, nonvalvular AF between 2004 and 2012 were identified who had at least 1 outpatient encounter with primary care or cardiology within 90 days of the AF diagnosis. Cox proportional hazards regression was used to evaluate the association between treating specialty and AF outcomes. RESULTS: Among 184,161 patients with newly diagnosed AF (age 70 ± 11 years; 1.7% women; CHA2DS2-VASc score 2.6 ± 1.7), 40% received cardiology care and 60% received primary care only. After adjustment for covariates, cardiology care was associated with reductions in stroke (hazard ratio [HR]: 0.91; 95% confidence interval [CI]: 0.86 to 0.96; p < 0.001) and death (HR: 0.89; 95% CI: 0.88 to 0.91; p < 0.0001) and increases in hospitalizations for AF/supraventricular tachycardia (HR: 1.38; 95% CI: 1.35 to 1.42; p < 0.0001) and myocardial infarction (HR: 1.03; 95% CI: 1.00 to 1.05; p < 0.04). The propensity-matched cohort had similar results. In mediation analysis, oral anticoagulation prescription within 90 days of diagnosis may have mediated reductions in stroke but did not mediate reductions in survival. CONCLUSIONS: In patients with newly diagnosed AF, cardiology care was associated with improved outcomes, potentially mediated by early prescription of oral anticoagulation therapy. Although hypothesis-generating, these data warrant serious consideration and study of health care system interventions at the time of new AF diagnosis. Published by Elsevier Inc.
BACKGROUND:Atrial fibrillation (AF) occurs in many clinical contexts and is diagnosed and treated by clinicians across many specialties. This approach has resulted in treatment variations. OBJECTIVES: The goal of this study was to evaluate the association between treating specialty and AF outcomes among patients newly diagnosed with AF. METHODS: Using data from the TREAT-AF (Retrospective Evaluation and Assessment of Therapies in AF) study from the Veterans Health Administration, patients with newly diagnosed, nonvalvular AF between 2004 and 2012 were identified who had at least 1 outpatient encounter with primary care or cardiology within 90 days of the AF diagnosis. Cox proportional hazards regression was used to evaluate the association between treating specialty and AF outcomes. RESULTS: Among 184,161 patients with newly diagnosed AF (age 70 ± 11 years; 1.7% women; CHA2DS2-VASc score 2.6 ± 1.7), 40% received cardiology care and 60% received primary care only. After adjustment for covariates, cardiology care was associated with reductions in stroke (hazard ratio [HR]: 0.91; 95% confidence interval [CI]: 0.86 to 0.96; p < 0.001) and death (HR: 0.89; 95% CI: 0.88 to 0.91; p < 0.0001) and increases in hospitalizations for AF/supraventricular tachycardia (HR: 1.38; 95% CI: 1.35 to 1.42; p < 0.0001) and myocardial infarction (HR: 1.03; 95% CI: 1.00 to 1.05; p < 0.04). The propensity-matched cohort had similar results. In mediation analysis, oral anticoagulation prescription within 90 days of diagnosis may have mediated reductions in stroke but did not mediate reductions in survival. CONCLUSIONS: In patients with newly diagnosed AF, cardiology care was associated with improved outcomes, potentially mediated by early prescription of oral anticoagulation therapy. Although hypothesis-generating, these data warrant serious consideration and study of health care system interventions at the time of new AF diagnosis. Published by Elsevier Inc.
Entities:
Keywords:
anticoagulation; atrial fibrillation; outcomes; quality of care; stroke
Authors: Yoko Miyasaka; Marion E Barnes; Bernard J Gersh; Stephen S Cha; Kent R Bailey; Walter P Abhayaratna; James B Seward; Teresa S M Tsang Journal: Circulation Date: 2006-07-03 Impact factor: 29.690
Authors: David Conen; Claudia U Chae; Robert J Glynn; Usha B Tedrow; Brendan M Everett; Julie E Buring; Christine M Albert Journal: JAMA Date: 2011-05-25 Impact factor: 56.272
Authors: Jeroen M L Hendriks; Rianne de Wit; Harry J G M Crijns; Hubertus J M Vrijhoef; Martin H Prins; Ron Pisters; Laurent A F G Pison; Yuri Blaauw; Robert G Tieleman Journal: Eur Heart J Date: 2012-03-27 Impact factor: 29.983
Authors: Ahmed M Selim; Jeremy A Mazurek; Muhammad Iqbal; Dan Wang; Abdissa Negassa; Ronald Zolty Journal: Clin Cardiol Date: 2015-02-18 Impact factor: 2.882
Authors: S E Reis; R Holubkov; D Edmundowicz; D M McNamara; K A Zell; K M Detre; A M Feldman Journal: J Am Coll Cardiol Date: 1997-09 Impact factor: 24.094
Authors: Alexander C Perino; Jun Fan; Mariam Askari; Paul A Heidenreich; Edmund Keung; Merritt H Raitt; Jonathan P Piccini; Paul D Ziegler; Mintu P Turakhia Journal: Circulation Date: 2019-03-17 Impact factor: 29.690
Authors: Andrew Young Chang; Mariam Askari; Jun Fan; Paul A Heidenreich; P Michael Ho; Kenneth W Mahaffey; Aditya Jathin Ullal; Alexander Carroll Perino; Mintu P Turakhia Journal: Clin Cardiol Date: 2018-09-22 Impact factor: 2.882
Authors: Faye L Norby; Pamela L Lutsey; Nathan D Shippee; Lin Y Chen; Carrie Henning-Smith; Alvaro Alonso; Rob F Walker; Aaron R Folsom Journal: Am J Cardiovasc Drugs Date: 2021-10-11 Impact factor: 3.283
Authors: Jung Myung Lee; Tae Hoon Kim; Myung Jin Cha; Junbeom Park; Jin Kyu Park; Ki Woon Kang; Jaemin Shim; Jae Sun Uhm; Jun Kim; Hyung Wook Park; Young Soo Lee; Eue Keun Choi; Chang Soo Kim; Boyoung Joung; Jin Bae Kim Journal: Korean Circ J Date: 2018-06 Impact factor: 3.243
Authors: Wesley T O'Neal; Pratik B Sandesara; J'Neka S Claxton; Richard F MacLehose; Lin Y Chen; Lindsay G S Bengtson; Alanna M Chamberlain; Faye L Norby; Pamela L Lutsey; Alvaro Alonso Journal: J Am Heart Assoc Date: 2018-03-10 Impact factor: 5.501
Authors: Wesley T O'Neal; Pratik B Sandesara; J'Neka S Claxton; Richard F MacLehose; Lin Y Chen; Lindsay G S Bengtson; Alanna M Chamberlain; Faye L Norby; Pamela L Lutsey; Alvaro Alonso Journal: Am J Cardiol Date: 2018-05-01 Impact factor: 2.778
Authors: Wesley T O'Neal; J'Neka S Claxton; Pratik B Sandesara; Richard F MacLehose; Lin Y Chen; Lindsay G S Bengtson; Alanna M Chamberlain; Faye L Norby; Pamela L Lutsey; Alvaro Alonso Journal: J Am Coll Cardiol Date: 2018-10-16 Impact factor: 24.094
Authors: Celina M Yong; Jennifer A Tremmel; Maarten G Lansberg; Jun Fan; Mariam Askari; Mintu P Turakhia Journal: J Am Heart Assoc Date: 2020-05-12 Impact factor: 5.501